Search our news archive and pharma companies
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Roche
steps up preparedness level over swine flu 7:45 AM 4/29/2009 Reuters - USA Roche Holding AG is working closely with the World Health Organization to make its
Tamiflu drug available to patients following the outbreak.
...
Antigenics
brain cancer vaccine gets orphan drug status 6:46 AM 4/29/2009 Reuters - USA Antigenics Inc said its experimental vaccine Oncophage received
orphan drug designation from the US FDA for the treatment of brain cancer.
...
Sanofi
halts work on 3 late-stage trial drugs 5:53 AM 4/29/2009 Forbes - NY,USA Sanofi-Aventis halts development of three Phase III drugs followed a review of
its R&D pipeline. It also axes several Phase II drugs and six projects that were in Phase I.
...
More
Novartis patients relapse-free with MS drug 5:33 AM 4/29/2009 Reuters - USA A study shows that 80-83 percent of patients taking its multiple
sclerosis drug FTY720 are relapse-free compared to 69 percent of those on the leading current treatment -
Biogen's injectable Avonex.
...
Dendreon
Prostate Drug Extends Life 4 Months 2:48 PM 4/28/2009 Bloomberg - USA Dendreon Corp’s prostate cancer therapy Provenge may some day be the first US
FDA approved malignancy-fighting immune booster. It extended men’s lives by four months in a study.
...
UCB
reports mixed results for epilepsy drug 5:13 AM 4/28/2009 Reuters - USA UCB reported mixed results of phase III trials for its planned epilepsy drug
brivaracetam. One of two studies met primary endpoints for efficacy.
...
Glaxo
drug cuts risk of prostate cancer 1:39 PM 4/27/2009 Reuters - USA The Reduce study found Avodart (dutasteride) significantly reduced the risk of all
biopsy-detectable prostate cancer by 23 percent over four years compared to placebo.
...
Human
Genome Sciences releases results for hepatitis C
drug 1:09 PM 4/27/2009 Bizjournals.com -
Charlotte,NC,USA Human Genome Sciences Inc released final results from the last stage of clinical
trials of its hepatitis C drug Albuferon.
...
Children
who get ADHD drugs score higher on tests 11:01 AM 4/27/2009 Reuters - USA Children diagnosed with ADHD from kindergarten through fifth grade
who were prescribed drugs such as Ritalin and Adderall performed better on standardized tests than unmedicated
peers with ADHD.
...
XenoPort's
diabetic pain drug fails in mid-stage trial 9:21 AM 4/27/2009 Reuters - USA XenoPort Inc's experimental drug XP13512 to treat diabetic
neuropathic pain failed to meet the main goal of a mid-stage study.
...
Glaxo
working to increase Relenza drug production 9:19 AM 4/27/2009 Reuters - USA GlaxoSmithKline Plc is trying to increase production of Relenza. The
drug and Tamiflu are effective against the deadly new strain of swine flu.
...
Pharming
drug gets FDA orphan status, shares jump 6:26 AM 4/27/2009 Reuters - USA Pharming said Prodarsan had been awarded an Orphan Drug designation
for the treatment of Cockayne Syndrome by the US FDA. Cockayne Syndrome is a rare genetic disease in which
children suffer from accelerated (or premature) aging.
...
Bayer
drug Nexavar ineffective against skin cancer 3:53 AM 4/27/2009 Reuters - USA Bayer and Onyx Pharmaceuticals said its Nexavar drug failed to work
against skin cancer in a late-stage clinical trial. The drug has already proven successful against liver and
kidney cancer.
...
Swine flu could boost drug
makers, hit tourism and trade 3:18 PM 4/26/2009 Reuters - USA Swine flu has killed up to 81 people in Mexico and infected others in the United
States, Canada, Europe, and New Zealand. Tamiflu and Relenza are both recommended drugs shown to work against the
new disease.
...
FDA
clears potential blockbuster arthritis drug 6:45 AM 4/25/2009 The Associated Press The US FDA approved Simponi (golimumab) for rheumatoid arthritis, psoriatic
arthritis and ankylosing spondylitis, a painful, progressive form of spinal arthritis.
...
<- Day Earlier | Today's News
|